Orphan Drug

Drugs that are not developed by the pharmaceutical industry for economic reasons but which respond to public health need. Orphan drugs are intended to treat diseases so rare that sponsors are reluctant to develop them under regular marketing conditions. The process from the discovery of a new molecule to its marketing is long, expensive and very uncertain. Developing a drug expecting to treat a rare disease does not allow the recovery of the capital invested for its research.

    Related Conference of Orphan Drug

    February 27-28, 2019

    2nd Global Experts Meeting on Infectious Diseases

    | Radisson Hotel Narita | Tokyo, Japan
    March 13-14, 2019

    12th World Congress on Virology and Infectious Diseases

    | Holiday Inn Atrium | Singapore
    April 08-09, 2019

    2nd Global experts meet on STD-AIDS and Infectious Diseases

    Wellington, New Zealand
    June 17-18, 2019

    9th World Congress on Rare Diseases and Orphan Drugs

    Berlin, Germany
    July 29-30, 2019

    Annual Meeting on Infectious Diseases

    Amsterdam, Netherlands
    September 09-10, 2019

    12thGlobal Infections Conference

    Holiday Inn Atrium | Singapore
    September 16-17, 2019

    10th International Conference on Emerging Infectious Diseases

    Brussels, Belgium
    September 23-24, 2019

    10th Annual Congress on Rare Diseases and Orphan Drugs

    Toronto | Canada
    September 23-24, 2019

    11th Euro-Global Conference on Infectious Diseases

    London, UK
    October 21-22, 2019

    9th Asia Pacific STD and Infectious Diseases Congress

    Hotel Radisson | Tokyo Japan
    November 19-20, 2019

    7th Annual Conference on Parasitology & Infectious Diseases

    Cape Town, South Africa

    Orphan Drug Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in